chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Eye irritation, Eyelid oedema, Headache, Ocular hyperaemia, Oropharyngeal pain
Clinical narrative: This non serious case was extracted from the VAERS database via QScan on 1 March 2009 (reference 295137). A 54-year-old female patient had received a second dose intramuscular injection FLUZONE SV 2007-2008, lot number U2514AA on 30 October 2007 at 20:30 hours and five hours later 01:30 hours, she developed a progressive headache, sniffles, a sore throat and burning of her eyes. At 06:45 hours, the sclera and conjunctiva of her eyes were very red and moist with mild eyelid edema. The patient denied any shortness of breath or rash. The patient's recovery status was not reported and no additional information was provided at the time of this report.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Rhinorrhoea
Clinical narrative: This non serious case was extracted from the VAERS database via QScan on 1 March 2009 (reference 295137). A 54-year-old female patient had received a second dose intramuscular injection FLUZONE SV 2007-2008, lot number U2514AA on 30 October 2007 at 20:30 hours and five hours later 01:30 hours, she developed a progressive headache, sniffles, a sore throat and burning of her eyes. At 06:45 hours, the sclera and conjunctiva of her eyes were very red and moist with mild eyelid edema. The patient denied any shortness of breath or rash. The patient's recovery status was not reported and no additional information was provided at the time of this report.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chills, Dysphonia, Eye discharge, Nasopharyngitis
Clinical narrative: Ocular hyperaemia; Nasopharyngitis; chest discomfort; sleep disorder; sinus congestion; dysphonia; rhinorrhoea; chills. This non serious case was extracted  from the VAERS database via QSCAN on 11 March 2009 (reference number 296653). A 67 year old female patient received Fluzone SV 2007-2008 (lot number U2493AA) intramuscularly on 08 November 2007 at 2:50 PM. By 5:15 PM the patient's voice became hoarse, chest tight, mucus, eyes were red and mucusy, cold, chills, runny nose, and sinus congestion. She slept off and on. She went to work and came home after one hour and slept. She felt better by 6:30 PM and had recovered. List of Documents held by Sender: none.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Rhinorrhoea, Sinus congestion, Sleep disorder
Clinical narrative: Ocular hyperaemia; Nasopharyngitis; chest discomfort; sleep disorder; sinus congestion; dysphonia; rhinorrhoea; chills. This non serious case was extracted  from the VAERS database via QSCAN on 11 March 2009 (reference number 296653). A 67 year old female patient received Fluzone SV 2007-2008 (lot number U2493AA) intramuscularly on 08 November 2007 at 2:50 PM. By 5:15 PM the patient's voice became hoarse, chest tight, mucus, eyes were red and mucusy, cold, chills, runny nose, and sinus congestion. She slept off and on. She went to work and came home after one hour and slept. She felt better by 6:30 PM and had recovered. List of Documents held by Sender: none.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Conjunctivitis, Cough, Dry mouth, Dyspnoea
Clinical narrative: This case was received on 11 March 2009 from VAERS (reference number 194435) via a search of the QSCAN database. A 79 year old female patient received FLUZONE (lot number U0688AA) intramuscularly on 31 October 2002. FLUZONE was noted to have an expiration date of 30 June 2002. On 05 November 2002 the patient developed trouble breathing while sleeping, dry throat, red itchy eyes, became very tired, cough, and a runny nose. The patient was reported as recovered. List of documents held by sender: none.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Eye pruritus, Fatigue, Ocular hyperaemia, Rhinitis, Rhinorrhoea
Clinical narrative: This case was received on 11 March 2009 from VAERS (reference number 194435) via a search of the QSCAN database. A 79 year old female patient received FLUZONE (lot number U0688AA) intramuscularly on 31 October 2002. FLUZONE was noted to have an expiration date of 30 June 2002. On 05 November 2002 the patient developed trouble breathing while sleeping, dry throat, red itchy eyes, became very tired, cough, and a runny nose. The patient was reported as recovered. List of documents held by sender: none.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Blood culture negative, Cough, Culture negative, Culture urine negative, Eye discharge
Clinical narrative: Initial report extracted from VAERS database via QSCAN report on 11 March 2009 (VAERS identification number 229204). A 76 year old male patient had received on 06 November 2004 an intramuscular injection of FLUZONE SV 2004-2005. "Ocularespiratory syndrome" patient experienced sinus congestion and eye drainage approximately 24 hours after receiving the FLUZONE vaccine that progressed to a cough with increased rhonchi, and catarrhal film over eyes. The patient was treated with pseudoephedrine, cefazolin 1 gm IVPB (times 2 or 3 doses) and levoflaxocin. Two days later on 08 November 2004, the eye secretions were cultured, a haemophilus influenza urine culture was done, and a Strep A glaciated (group B) blood culture was done. All cultures revealed no growth. The patient recovered (date not reported). The event of Oculorespiratory syndrome was reported by VAERS, but was not coded by VAERS. This case was coded as Ocular-Respiratory syndrome with symptoms that were coded by VAERS as rhinitis, conjunctivitis, cough and respiratory disorder as co-manifestation.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Nasopharyngitis, Oculorespiratory syndrome, Rhonchi, Sinus congestion
Clinical narrative: Initial report extracted from VAERS database via QSCAN report on 11 March 2009 (VAERS identification number 229204). A 76 year old male patient had received on 06 November 2004 an intramuscular injection of FLUZONE SV 2004-2005. "Ocularespiratory syndrome" patient experienced sinus congestion and eye drainage approximately 24 hours after receiving the FLUZONE vaccine that progressed to a cough with increased rhonchi, and catarrhal film over eyes. The patient was treated with pseudoephedrine, cefazolin 1 gm IVPB (times 2 or 3 doses) and levoflaxocin. Two days later on 08 November 2004, the eye secretions were cultured, a haemophilus influenza urine culture was done, and a Strep A glaciated (group B) blood culture was done. All cultures revealed no growth. The patient recovered (date not reported). The event of Oculorespiratory syndrome was reported by VAERS, but was not coded by VAERS. This case was coded as Ocular-Respiratory syndrome with symptoms that were coded by VAERS as rhinitis, conjunctivitis, cough and respiratory disorder as co-manifestation.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Asthma, Conjunctivitis, Cough, Dyspnoea, Eye irritation
Clinical narrative: Asthma, conjunctivitis, cough increased, dyspnea. Initial report extracted from VAERS database via QSCAN report on 11 March 2009 (VAERS identification number 245175). A 46 year old female patient had received on 29 September 2005 a second intramuscular injection of FLUZONE SV 20005-2006 (lot number U1778AA). It was reported the patient developed a cough, wheezing, shortness of breath and red irritated eyes. It was not reported whether any relevant diagnostic tests or laboratory data were performed. Treatment was not reported. VAERS coded the events as asthma, conjunctivitis, increasing cough and dyspnea. The patient recovered.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Wheezing
Clinical narrative: Asthma, conjunctivitis, cough increased, dyspnea. Initial report extracted from VAERS database via QSCAN report on 11 March 2009 (VAERS identification number 245175). A 46 year old female patient had received on 29 September 2005 a second intramuscular injection of FLUZONE SV 20005-2006 (lot number U1778AA). It was reported the patient developed a cough, wheezing, shortness of breath and red irritated eyes. It was not reported whether any relevant diagnostic tests or laboratory data were performed. Treatment was not reported. VAERS coded the events as asthma, conjunctivitis, increasing cough and dyspnea. The patient recovered.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Asthma, Chills, Conjunctivitis, Cough, Eye discharge
Clinical narrative: This case was extracted from VAERS via QScan on 11 march 2009 (reference number 246564). A 49-year-old female received an intramuscular injection of FLUZONESV '2005-'2006 USP (lot number U1838AA) on 27 October 2005. Within a few minutes of vaccination, her throat became swollen. Two to three hours post-vaccination she complained of "water in my lungs". Four hours post-vaccination she developed coughing and wheezing, and her eyes became swollen and inflamed with discharge. She had a low-grade fever (99.9 degrees) and later developed chills and nausea. The following day she felt achy and cold, and treatment included an antihistamine. Outcome was not reported.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Eye swelling, Face oedema, Headache, Immediate post-injection reaction, Laryngospasm
Clinical narrative: This case was extracted from VAERS via QScan on 11 march 2009 (reference number 246564). A 49-year-old female received an intramuscular injection of FLUZONESV '2005-'2006 USP (lot number U1838AA) on 27 October 2005. Within a few minutes of vaccination, her throat became swollen. Two to three hours post-vaccination she complained of "water in my lungs". Four hours post-vaccination she developed coughing and wheezing, and her eyes became swollen and inflamed with discharge. She had a low-grade fever (99.9 degrees) and later developed chills and nausea. The following day she felt achy and cold, and treatment included an antihistamine. Outcome was not reported.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Malaise, Myalgia, Nausea, Pain, Pharyngeal oedema
Clinical narrative: This case was extracted from VAERS via QScan on 11 march 2009 (reference number 246564). A 49-year-old female received an intramuscular injection of FLUZONESV '2005-'2006 USP (lot number U1838AA) on 27 October 2005. Within a few minutes of vaccination, her throat became swollen. Two to three hours post-vaccination she complained of "water in my lungs". Four hours post-vaccination she developed coughing and wheezing, and her eyes became swollen and inflamed with discharge. She had a low-grade fever (99.9 degrees) and later developed chills and nausea. The following day she felt achy and cold, and treatment included an antihistamine. Outcome was not reported.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Wheezing
Clinical narrative: This case was extracted from VAERS via QScan on 11 march 2009 (reference number 246564). A 49-year-old female received an intramuscular injection of FLUZONESV '2005-'2006 USP (lot number U1838AA) on 27 October 2005. Within a few minutes of vaccination, her throat became swollen. Two to three hours post-vaccination she complained of "water in my lungs". Four hours post-vaccination she developed coughing and wheezing, and her eyes became swollen and inflamed with discharge. She had a low-grade fever (99.9 degrees) and later developed chills and nausea. The following day she felt achy and cold, and treatment included an antihistamine. Outcome was not reported.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Dysphagia, Eye discharge, Eye swelling, Fatigue
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 246764). A 31-year-old female patient received an intramuscular injection of Fluzone sv 2005-2006 (lot number V1910AC) on 03 November 2005. Approximately three hours post-vaccination, she complained of her throat feeling completely shut. She could not swallow, and had slight wheezing. She drank some juice and some warm tea, but the symptoms persisted and she began to feel tired, so she went to bed. She also complained of feeling hot, with chills and teeth chattering. When she awoke several hours later, she noted that her eyes were puffy, swollen, and red, with phlegm in the corners. The patient subsequently recovered.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Ocular hyperaemia, Pharyngeal oedema, Wheezing
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 246764). A 31-year-old female patient received an intramuscular injection of Fluzone sv 2005-2006 (lot number V1910AC) on 03 November 2005. Approximately three hours post-vaccination, she complained of her throat feeling completely shut. She could not swallow, and had slight wheezing. She drank some juice and some warm tea, but the symptoms persisted and she began to feel tired, so she went to bed. She also complained of feeling hot, with chills and teeth chattering. When she awoke several hours later, she noted that her eyes were puffy, swollen, and red, with phlegm in the corners. The patient subsequently recovered.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Dizziness, Dyspnoea, Eye discharge, Pain
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 246876). A 55-year-old female patient received an intramuscular injection of FLUZONE SV '2005-'2006 USP (lot number U1771AA) on 05 November 2005. Approximately three hours after vaccination, the patient complained of her throat closing up, difficulty breathing, light-headedness, dizziness, coughing, and secretions from the eyes. She stated that it "felt like asthma". Later in the day she became achy all over, with ongoing eye secretions and cough. All events subsequently recovered.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Pharyngeal oedema
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 246876). A 55-year-old female patient received an intramuscular injection of FLUZONE SV '2005-'2006 USP (lot number U1771AA) on 05 November 2005. Approximately three hours after vaccination, the patient complained of her throat closing up, difficulty breathing, light-headedness, dizziness, coughing, and secretions from the eyes. She stated that it "felt like asthma". Later in the day she became achy all over, with ongoing eye secretions and cough. All events subsequently recovered.
Age: 30.0
Sex: M
Vaccine: FLU3
Symptoms: Conjunctivitis, Cough, Eye pruritus, Face oedema, Lacrimal disorder
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 247279). A 30-year-old male patient received an intramuscular injection of FLUZONE SV 2005-2006 (lot number U1846AA) on 10 November 2005. He experienced a generalized vaso-vagal response, was given orange juice, and returned to work. Approximately 45 minutes later, he presented to the emergency room or doctor complaining of a persistent dry cough, scratchy throat with puffiness, and tearing and itching of eyes. The events recovered.
Age: 30.0
Sex: M
Vaccine: FLU3
Symptoms: Lacrimation increased, Pharyngeal oedema, Pharyngitis, Presyncope, Syncope
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 247279). A 30-year-old male patient received an intramuscular injection of FLUZONE SV 2005-2006 (lot number U1846AA) on 10 November 2005. He experienced a generalized vaso-vagal response, was given orange juice, and returned to work. Approximately 45 minutes later, he presented to the emergency room or doctor complaining of a persistent dry cough, scratchy throat with puffiness, and tearing and itching of eyes. The events recovered.
Age: 30.0
Sex: M
Vaccine: FLU3
Symptoms: Throat irritation
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 247279). A 30-year-old male patient received an intramuscular injection of FLUZONE SV 2005-2006 (lot number U1846AA) on 10 November 2005. He experienced a generalized vaso-vagal response, was given orange juice, and returned to work. Approximately 45 minutes later, he presented to the emergency room or doctor complaining of a persistent dry cough, scratchy throat with puffiness, and tearing and itching of eyes. The events recovered.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Back pain, Conjunctivitis, Dyspnoea, Eye irritation, Eye pain
Clinical narrative: Shortness of breath, conjunctivitis, pain eye, back ache, fever, headache. This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009. (reference number 247416). A 53 year old female patient had received a first dose intramuscular injection of FLUZONE SV 2005-2006, lot number U1904AA on 01 November 2005 and four to five hours later, she complained of her eyes burning and hurting, shortness of breath and fever. The patient also experienced a headache and back ache. The symptoms reduced over 24 hours. The patient did not seek care at the reporter's clinic and was reported to have been recovered from the event. No further information was provided.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Pyrexia
Clinical narrative: Shortness of breath, conjunctivitis, pain eye, back ache, fever, headache. This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009. (reference number 247416). A 53 year old female patient had received a first dose intramuscular injection of FLUZONE SV 2005-2006, lot number U1904AA on 01 November 2005 and four to five hours later, she complained of her eyes burning and hurting, shortness of breath and fever. The patient also experienced a headache and back ache. The symptoms reduced over 24 hours. The patient did not seek care at the reporter's clinic and was reported to have been recovered from the event. No further information was provided.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Cough, Eye pain, Eye swelling, Headache
Clinical narrative: Initial report extracted from VAERS database via QSCAN FDA report on 11 March 2009 (VAERS identification number 247747). A 51-year-old female patient had received on 15 November 2005 at 10:30 am a dose of Fluzone SV 2005-2006 USP (lot number U1819AA). The route and site of administration were not reported. Approximately four hours later, at around 14:30 pm, the patient's eyes started to bother her and a co-worker told her that her eyes were very red. Her throat was also beginning to get sore. On the train ride to another doctor's office her mouth began to feel swollen and she had the chills and started to cough. It was not reported whether any relevant diagnostic tests or laboratory data were performed, or if any treatment was received at that time. By the time the patient returned home, her body ached, her eyes and mouth were swollen and her head hurt. The patient drank some tea with lemon and honey, ate some Lipton chicken soup and too two Aleve. The patient recovered (date not reported). Documents held by sender: None
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Oedema mouth, Oropharyngeal pain, Pain
Clinical narrative: Initial report extracted from VAERS database via QSCAN FDA report on 11 March 2009 (VAERS identification number 247747). A 51-year-old female patient had received on 15 November 2005 at 10:30 am a dose of Fluzone SV 2005-2006 USP (lot number U1819AA). The route and site of administration were not reported. Approximately four hours later, at around 14:30 pm, the patient's eyes started to bother her and a co-worker told her that her eyes were very red. Her throat was also beginning to get sore. On the train ride to another doctor's office her mouth began to feel swollen and she had the chills and started to cough. It was not reported whether any relevant diagnostic tests or laboratory data were performed, or if any treatment was received at that time. By the time the patient returned home, her body ached, her eyes and mouth were swollen and her head hurt. The patient drank some tea with lemon and honey, ate some Lipton chicken soup and too two Aleve. The patient recovered (date not reported). Documents held by sender: None
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Chest discomfort, Chest pain, Chills, Conjunctivitis
Clinical narrative: This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 218804). A 53-year-old female patient with no reported medical history, had received an intramuscular injection of FLUZONE SV 2005-2006, lot number U1828AA (site not reported) on 03 November 2005 at approximately 15:45 pm. At approximately 19:15pm her throat began to feel like someone was cutting it with a knife and she became hoarse. Approximately 15 minutes later, she had been in bed laying down and began to have labored breathing as if something was heavy on her chest. She got up and went to the bathroom and noticed her bottom lip was swollen about 4-5 times it's normal size and the "scalera" in both eyes were beet red. The last sentence of the source document narrative report was incomplete and stated the following: "I was due to work overtime on the 1 --". Additional events of fever, chills, pain chest, edema face, conjunctivitis, pareathesia, and asthenia were coded in the source documents received from the reporter; However these events were not mentioned in the source document narrative. The outcome for the event was reported as emergency room or doctors visit (ER), and the patient's recovery status was not reported. No further information was provided. Documents held by sender: None.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Dysphonia, Dyspnoea, Face oedema, Lip swelling, Ocular hyperaemia
Clinical narrative: This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 218804). A 53-year-old female patient with no reported medical history, had received an intramuscular injection of FLUZONE SV 2005-2006, lot number U1828AA (site not reported) on 03 November 2005 at approximately 15:45 pm. At approximately 19:15pm her throat began to feel like someone was cutting it with a knife and she became hoarse. Approximately 15 minutes later, she had been in bed laying down and began to have labored breathing as if something was heavy on her chest. She got up and went to the bathroom and noticed her bottom lip was swollen about 4-5 times it's normal size and the "scalera" in both eyes were beet red. The last sentence of the source document narrative report was incomplete and stated the following: "I was due to work overtime on the 1 --". Additional events of fever, chills, pain chest, edema face, conjunctivitis, pareathesia, and asthenia were coded in the source documents received from the reporter; However these events were not mentioned in the source document narrative. The outcome for the event was reported as emergency room or doctors visit (ER), and the patient's recovery status was not reported. No further information was provided. Documents held by sender: None.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia, Pyrexia, Scleral hyperaemia, Throat irritation
Clinical narrative: This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 218804). A 53-year-old female patient with no reported medical history, had received an intramuscular injection of FLUZONE SV 2005-2006, lot number U1828AA (site not reported) on 03 November 2005 at approximately 15:45 pm. At approximately 19:15pm her throat began to feel like someone was cutting it with a knife and she became hoarse. Approximately 15 minutes later, she had been in bed laying down and began to have labored breathing as if something was heavy on her chest. She got up and went to the bathroom and noticed her bottom lip was swollen about 4-5 times it's normal size and the "scalera" in both eyes were beet red. The last sentence of the source document narrative report was incomplete and stated the following: "I was due to work overtime on the 1 --". Additional events of fever, chills, pain chest, edema face, conjunctivitis, pareathesia, and asthenia were coded in the source documents received from the reporter; However these events were not mentioned in the source document narrative. The outcome for the event was reported as emergency room or doctors visit (ER), and the patient's recovery status was not reported. No further information was provided. Documents held by sender: None.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Conjunctivitis, Cough, Eye irritation, Eye swelling, Face oedema
Clinical narrative: Conjunctivitis, cough, edema face, edema tongue, rhinitis. This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 248517).  A 52 year old female patient with no known allergies had received a first dose intramuscular injection of FLUZONE SV 2005-2006, lot number U1870AA on 16 November 2005 at 09:15 a.m., and by 13:00 pm the patient developed cough so she ate ice. Three hours later, she experienced burning, red and puffy eyes, her nasal airway was swollen- "no air" (coded by VAERS as rhinitis) and the back of her tongue was swollen. Corrective treatments included BENADRYL 25 mg x three and the patient went to sleep. The patient also experienced face edema which was included in the coding from VAERS database; however this was not mentioned in the narrative. The next day, the patient was reported to have been "okay" and recovered from the event.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Rhinitis, Swollen tongue
Clinical narrative: Conjunctivitis, cough, edema face, edema tongue, rhinitis. This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 248517).  A 52 year old female patient with no known allergies had received a first dose intramuscular injection of FLUZONE SV 2005-2006, lot number U1870AA on 16 November 2005 at 09:15 a.m., and by 13:00 pm the patient developed cough so she ate ice. Three hours later, she experienced burning, red and puffy eyes, her nasal airway was swollen- "no air" (coded by VAERS as rhinitis) and the back of her tongue was swollen. Corrective treatments included BENADRYL 25 mg x three and the patient went to sleep. The patient also experienced face edema which was included in the coding from VAERS database; however this was not mentioned in the narrative. The next day, the patient was reported to have been "okay" and recovered from the event.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Conjunctivitis, Dyspnoea, Nasal congestion, Productive cough
Clinical narrative: This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 248530). A 51-year-old female patient had received an intramuscular injection of FLUZONE SV 2005-2006 USP, lot number U1775AA on 13 October 2005 at 12:00 pm and three and a half hours later, she experienced nasal congestion (coded by VAERS as rhinitis), an over production of sputum, conjunctivitis and shortness of breath. The patient recovered from the event (date of recovery not reported). No additional information was provided. Documents held by sender: None.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Eye pruritus, Eye swelling, Fatigue, Headache
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 249423) via a search of the QSCAN database. A 43 year old female patient received FLUZONE SV '2005-'2006 USP (lot number reported as 49281037615) on 13 December 2005 at 10:40 AM. Thirty minutes later the patient developed fatigue. At approximately 3:30 PM the patient developed a fever, muscle aches, headache, cough, chest congestion and a sore throat. At 8 PM the patient's left eye became very red, itchy, and swollen. The patient treated the fever with Tylenol and the eye symptoms with ELESTAT. The patient recovered. List of Documents held by sender: None.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Ocular hyperaemia, Oropharyngeal pain, Pyrexia, Upper respiratory tract congestion
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 249423) via a search of the QSCAN database. A 43 year old female patient received FLUZONE SV '2005-'2006 USP (lot number reported as 49281037615) on 13 December 2005 at 10:40 AM. Thirty minutes later the patient developed fatigue. At approximately 3:30 PM the patient developed a fever, muscle aches, headache, cough, chest congestion and a sore throat. At 8 PM the patient's left eye became very red, itchy, and swollen. The patient treated the fever with Tylenol and the eye symptoms with ELESTAT. The patient recovered. List of Documents held by sender: None.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Chills, Conjunctivitis, Cough, Fatigue
Clinical narrative: This non serious case was received 11 March 2009 from VAERS (reference number 249662) via a search of QScan database. A 38 year old female patient received FLUZONE SV '2005-'2006 USP (lot number U1830AA) intramuscularly on 21 December 2005. Four hours post vaccination, the patient experienced a foreign body sensation in her throat and a dry cough. Six hours post vaccination she experienced fatigue, a low grade fever (temperature was not taken), uncontrollable chills/rigors, muscle aches throughout the entire body, and "injected eyes bloodshot". Seven hours post vaccination, the patient was treated with ADVIL 400mg. The patient had an improvement in her symptoms two hours after taking ADVIL. The patient had further improvement except for tiredness eight hours after taking ADVIL. The patient was reported recovered.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Laryngospasm, Myalgia, Ocular hyperaemia, Pyrexia, Throat irritation
Clinical narrative: This non serious case was received 11 March 2009 from VAERS (reference number 249662) via a search of QScan database. A 38 year old female patient received FLUZONE SV '2005-'2006 USP (lot number U1830AA) intramuscularly on 21 December 2005. Four hours post vaccination, the patient experienced a foreign body sensation in her throat and a dry cough. Six hours post vaccination she experienced fatigue, a low grade fever (temperature was not taken), uncontrollable chills/rigors, muscle aches throughout the entire body, and "injected eyes bloodshot". Seven hours post vaccination, the patient was treated with ADVIL 400mg. The patient had an improvement in her symptoms two hours after taking ADVIL. The patient had further improvement except for tiredness eight hours after taking ADVIL. The patient was reported recovered.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Cough, Dry eye, Hyperhidrosis, Nausea
Clinical narrative: Wheezing, cough, chest pain, pharyngolaryngeal pain, ocular hyperemia, dry eyes, nausea. Hyperhidrosis. This case was received on 11 March 2009 via a QSCAN search on the VAERS database, under reference number 296998. A 36 year old female patient whose medical history included allergies to sulfa, minocycline, and tetracycline antibiotics and IV Ferrlecit, received a second intramuscular injection of FLUZONE (lot # U2466AA) on 31 October 2007. Approximately four hours post vaccination, the patient experienced a gradual onset of a mild dull and achy chest pain, wheezing, sore throat, non-productive cough, and very dry and reddened eyes. At approximately 7 pm that evening, she felt mild nausea and sweaty palms. The patient researched her symptoms and believed that she experienced ORS (Oculo-Respiratory Syndrome). The symptoms resolved by the next day. The patient recovered.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Oropharyngeal pain, Pain, Wheezing
Clinical narrative: Wheezing, cough, chest pain, pharyngolaryngeal pain, ocular hyperemia, dry eyes, nausea. Hyperhidrosis. This case was received on 11 March 2009 via a QSCAN search on the VAERS database, under reference number 296998. A 36 year old female patient whose medical history included allergies to sulfa, minocycline, and tetracycline antibiotics and IV Ferrlecit, received a second intramuscular injection of FLUZONE (lot # U2466AA) on 31 October 2007. Approximately four hours post vaccination, the patient experienced a gradual onset of a mild dull and achy chest pain, wheezing, sore throat, non-productive cough, and very dry and reddened eyes. At approximately 7 pm that evening, she felt mild nausea and sweaty palms. The patient researched her symptoms and believed that she experienced ORS (Oculo-Respiratory Syndrome). The symptoms resolved by the next day. The patient recovered.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Cough, Eye pruritus, Eye swelling, Headache
Clinical narrative: This non serious was extracted from the VAERS database via QScan on 11 March 2009 (reference number 297137). A 57 year old female patient received an intramuscular injection of Fluzone SV 2007-2008 (lot number U2511AA) on 15 January 2007. At 6:00 PM on 15 November 2007 (corrected on 16 April 2009) the patient developed a dry cough with a tickle in her throat and swollen glands in her neck. At 6:30 PM her eye became bloodshot, swollen, itchy, breathing was shallow and rapid. At 8:30 PM the patient developed headache and felt chilled. At 2:00 AM the patient complained of a headache. She did not seek medical care. The patient was reported as recovered.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoventilation, Lymphadenopathy, Ocular hyperaemia, Respiratory rate increased, Throat irritation
Clinical narrative: This non serious was extracted from the VAERS database via QScan on 11 March 2009 (reference number 297137). A 57 year old female patient received an intramuscular injection of Fluzone SV 2007-2008 (lot number U2511AA) on 15 January 2007. At 6:00 PM on 15 November 2007 (corrected on 16 April 2009) the patient developed a dry cough with a tickle in her throat and swollen glands in her neck. At 6:30 PM her eye became bloodshot, swollen, itchy, breathing was shallow and rapid. At 8:30 PM the patient developed headache and felt chilled. At 2:00 AM the patient complained of a headache. She did not seek medical care. The patient was reported as recovered.
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Pain, Rotator cuff syndrome
Clinical narrative: Impingement syndrome. Pain in joint involving shoulder region. Initial report received on 25 March 2009 from a physician, who is also the patient. The initial report was received by Sanofi Aventis under the following reference numbers: Activity inquiry 1-201292577 and parent inquiry 1-201270726.  Follow up information was also received on 30 March 2009. A 36 year old male (who is a physician), with no history of impingement syndrome or left shoulder pain, received an injection of FLUZONE (lot number not reported) in October 2008. According to the patient, the nurse aimed too high and he believed that the injection went into the left subacromial bursa. Two or three days post vaccination, the patient experienced pain for the first time in the left subacromial area and shoulder. The symptoms were the same as impingement syndrome and continued. One of the patient's partner's an orthopedist, injected the shoulder with steroids three times since them, the most recent time a few weeks ago. At the time of the report, the patient was symptom free. If the symptoms return, he planned to undergo an MRI of the shoulder to look for the etiologies.
Sex: F
Vaccine: FLU3
Symptoms: Limb discomfort
Clinical narrative: Initial report received on 03 April 2009 from a health professional. A female patient, whose age and medical history were not reported, received Fluzone (lot number not reported) on an unspecified date and developed "leg problems". The patient was seen by a neurologist. At the time of the report, no other details were known.
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Hyperhidrosis, Pruritus, Skin warm
Clinical narrative: This case was received from a family nurse pracitionter on 22 June 2009. A male patient received an injection of influenza vaccine (manufacturer, date of administration, and lot number not reported). He later experienced red, hot, itchy skin, and also complained of being sweaty. He was seen in the emergency room, but was not admitted. No additional information was reported. Follow up information received on 17 July 2009 from health professional. The patient received FLUZONE SV(date not provided). The patient was given a "shot" (medication not known) in the emergency room as treatment. The patient was reported as being treated in the emergency room in "?2007". The patient recovered, date not provided. No further information reported.
Age: 16.0
Sex: M
Vaccine: FLU3, HEPA, MNQ
Symptoms: Antibody test negative, Laboratory test
Clinical narrative: Initial report was received 06 July 2009 from a consumer who is also the patient's parent. An 18-year-old male patient with a medical history of mild to moderate scoliosis and seasonal allergies, had received an injection of Menactra, lot number U2351AA (route and site not reported) on 22 September 2007, and 641 days later, his parent had laboratory titers performed which showed the patient did not have protection against tow of the serogroups. The patient had no illness at the time of vaccination and he had not been taking any concomitant medications. It was reported that the patient had not been evaluated by their physician. Laboratory testing was performed on 24 June 2009 for Meningridis A/C/W-235?Y with the following 1gG ug/mL results: Type A IgG-2.4 ug/mL, type C InG-0.1 ug/mL and Type W-135 - 1.2 -2.0 ug/mL: Equivocal, and 2.1 ug/mL or greater: Suggestive of protection. In addition, there were handwritten notes on the lab report dated 06/Jul/(year illegible) which stated, "Meningitis Bacteria, (+) immunity to meingitis Type A. Recommend infectious dx (illegible word)". No further information was provided at the time of the report. Follow up information received on 04 August 2009 from a health care professional. At the time of vaccination, the patient was recovering from pharyncitis. The patient received a first time dose of Menactra intramuscularly in the right arm, a second dose of Fluzone SV 2007-2008 (lot number U2436AA) intramuscularly in the left arm and the first does of HAVRIX (lot number AHAVB177AA) intramuscularly in the arm all received on 22 September 2007. Between November 2007 and March 2009 the patient was transferred to a new primary care physician. The patient's mother did not have the patient's records, therefore she was unsure if the patient had received the vaccine previously. Subsequently titers were ordered. The patient's mother contacted the reporter regarding the lab results. The reporter stated that the patient would have to follow up with his new physician to review the findings. Per the patient's mother, the new physician recommended that the patient follow up with an infectious disease specialist. Reovery status was not known. No additional information was provided. Follow up information received on 11 September 2009 from a health care professional who reported that the patient received  the meningococcal vaccine while in hight schoo. Titer levels were assessed to assure appropriate immunity since the patient was attending college. Based on the results, the patient was recovered from the even. No further information was provided.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site haematoma, Injection site haemorrhage, Injection site mass
Clinical narrative: A 70-year-old male patient, who had no concurrent illnesses or allergies, but whose medical history was questionable as he was taking Aspirin at the time, had received a dose of Fluzone SV 2009-2010 (lot number U3196AA) on 02 September 2009. Right after receiving the vaccination, the patient developed a "bump" or mass and bruise and bleeding at the injection site. It was not reported whether the patient required medical evaluation or if he received any treatment, but no diagnosis testing or laboratory data were performed. At the time of this report, the injection site was still bruised. The patient had not recovered. The reporter for this case is the same as for case 2009-03720. Documents held by sender: None
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Discomfort, Erythema, Mass, Skin warm, Vaccination complication
Clinical narrative: Initial report received on 14 September 2009 from a health care professional. A 4 year old female patient with no reported past medical history developed a reaction 2 hours and 45 minutes after receiving FLUZONE SV 2009-2010 (lot number U3186AA) intramuscularly on 10 September 2009 at 3:15 PM . At 6:00 PM, the patient developed a 2 to 3 inch red, circular lump, hot to touch and some discomfort. No treatment was required. The patient recovered. No other information was provided.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain upper, Chest pain, Chills, Headache, Muscle spasms
Clinical narrative: Chest pain, stomach pain, back muscle spasms, shaking, chills, head pain, muscle ache, fever. Initial report received on 14 September 2009 from a health care professional in the United States. A 39-year-old female patient, who had no concurrent illnesses, but has medical conditions  of seasonal allergies and asthma for which she takes ALLEGRA D and PULMICORT as needed, had received a yearly intramuscular left deltoid injection of FLUZONE SV 2009-2010 on 10 September 2009 at 14:00 hours. Four hours post vaccination, the patient started having muscle aches, shaking chills, back spasms, stomach, chest and head pain and fever. It was not reported whether the patient received any treatment.  At the time of this report, the patient had recovered (date not reported.) Documents held by sender: None.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Pyrexia, Tremor
Clinical narrative: Chest pain, stomach pain, back muscle spasms, shaking, chills, head pain, muscle ache, fever. Initial report received on 14 September 2009 from a health care professional in the United States. A 39-year-old female patient, who had no concurrent illnesses, but has medical conditions  of seasonal allergies and asthma for which she takes ALLEGRA D and PULMICORT as needed, had received a yearly intramuscular left deltoid injection of FLUZONE SV 2009-2010 on 10 September 2009 at 14:00 hours. Four hours post vaccination, the patient started having muscle aches, shaking chills, back spasms, stomach, chest and head pain and fever. It was not reported whether the patient received any treatment.  At the time of this report, the patient had recovered (date not reported.) Documents held by sender: None.
Sex: M
Vaccine: FLU3
Symptoms: Pruritus
Clinical narrative: An unidentified male patient, had received a dose of FLUZONE SV 2009-2010 on an unspecified date. The lot number, route and site of administration was not reported. At an unspecified amount of time later, the patient developed a 7cm by 9cm area that was "purplish" in color, but not raised (site not reported). The patient was also itchy. At the time of this report, the patient was no longer complaining of itching, and the purplish color was ongoing. Documents held by sender: None
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Hallucination, visual
Clinical narrative: Visual hallucinations. Initial non-serious case received from a patient's parent on 17 October 2008. A two year old male patient received an intramuscular right thigh injection of FLUZONE No Preservative 2008-2009 (lot number UT2785DA) and 15 - 20 minutes later, while riding home in the car, the child was having "hallucinations" in which he saw a dog in the car and a snake in the car seat. The patient returned to the doctor's office and was being seen by the physician at the time of the report. Patient outcome was unknown. Follow-up information was received from a physician on 17 November 2008. The patient recovered from the event. It was reported that at the time of the doctor's visit, the patient was doing fine and had not experienced any more hallucinations.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Dysgeusia, Hyperhidrosis, Nausea
Clinical narrative: A 69 year old female patient with a history of " a reaction to butyl alcohol contained in a epidural injection which resulted in hospitalization" received a left deltoid intramuscular injection of FLUZONE on on 15 October 2008. Thirty minutes post vaccination the patient developed nausea, a metallic taste in her mouth, and diaphoresis. The patient was advised to see her family physician. No further information was provided. Follow-up information received on 23 February 2009 from the health care professional. Per the reporter, it is unknown what the recovery status of the patient is. No further information is expected. List of Documents held by Sender: None.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site atrophy, Injection site induration, Injection site necrosis
Clinical narrative: Injection site necrosis - Injection site atrophy. Initial report was received on 19 November 2008 from a health care professional in the USA. A 45 year old female patient received a left deltoid intramuscular injection of FLUZONE No Preservative 2008-2009 (lot number U2797BA) on 22 October 2008. On 18 November 2008 the patient noticed that she had a red, dime sized indentation on the left deltoid where she had the injection. The area was not inflamed or painful. The nurse stated that the area looked like tissue necrosis. The patient is scheduled to visit with her doctor on 19 November 2008. The patient was not recovered at the time of the report. List of Documents held by Sender: None.
Age: 46.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Erythema, Eye pruritus, Fatigue, Pharyngeal oedema
Clinical narrative: Initial report received from a consumer on 07 November 2008. A 46-year-old male patient had received a dose of FLUZONE (lot number U2810AA, route and site of administration not reported) on 06 November 2008 and within one hour, his eyes became itchy, face became red and he felt like his throat was closing. The patient used his asthma inhaler with some benefit. The patient also complained of fever of 102 degrees Fahrenheit, chills and vomiting that evening. On the day of the report, patient outcome was "not recovered". The patient reported feeling better although "not great", and indicated that he felt very tired. Documents held by sender: none
Age: 46.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Vomiting
Clinical narrative: Initial report received from a consumer on 07 November 2008. A 46-year-old male patient had received a dose of FLUZONE (lot number U2810AA, route and site of administration not reported) on 06 November 2008 and within one hour, his eyes became itchy, face became red and he felt like his throat was closing. The patient used his asthma inhaler with some benefit. The patient also complained of fever of 102 degrees Fahrenheit, chills and vomiting that evening. On the day of the report, patient outcome was "not recovered". The patient reported feeling better although "not great", and indicated that he felt very tired. Documents held by sender: none
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Confusional state, Rash pruritic
Clinical narrative: A 42-year-old female patient, with no reported medical history, received a left arm intramuscular injection of FLUZONE SV 2009-2010 (lot number U3186AA) on 11 September 2009. The day after vaccination, she developed itchy bumps on her face and neck. She also reported "acting confused" the night after vaccination. The patient reported that she was no longer confused, but the itchy bumps were ongoing. She noted that she had received FLUZONE injections for many years.
Age: 68.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Dizziness, Tremor
Clinical narrative: Tremor, weakness, dizziness,. this non-serious case was received from a patient on 05 December 2008. A 68 year old male patient, with a history of thimerosal and penicillin allergies and a heart rhythm abnormality, received an intramuscular left deltoid injection of FLUZONE SV 2008-2009 (lot number U2791AA) on 13 October 2008. Eight hours post-vaccination, he experienced weakness, tremors, and dizziness. The events lasted for several hours. The patient reported the events via phone call to his physician, who prescribed TYLENOL. Outcome was unknown. Follow-up information received 16 January 2009 from a health care professional who reviewed the case information, had no new relevant medically significant information to provide at this time. Follow-up information received 13 April 2009 from a health care professional who reported that the patient recovered from the events. No additional information was provided.